financialcontent

AINewsBreaks – McEwen Inc. (NYSE: MUX) (TSX: MUX) Schedules Third Quarter 2026 Results Conference Call for Nov. 10

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.
financialcontent

Akamis Bio to Present Data from a Phase 1 Study of NG-348 in Patients with Advanced Epithelial Tumors at SITC 2026

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Akamis Bio, a clinical-stage oncology company working ...
financialcontent

RGP Study: 89% of CFOs Report Positive Financial Outlook, Yet Nearly Half Say Transformation Demands Exceed Capacity

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Second annual CFO Perspectives research reveals an ...
financialcontent

GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. New AI-assisted capabilities expand the Vscan Air ...
financialcontent

A2 Biotherapeutics Presents Updated Safety and Efficacy Data from EVEREST-2 and DENALI-1 Clinical Studies during 2026 Annual Meeting of the Society for Immunotherapy of Cancer

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. EVEREST-2 findings include update on first complete ...